US-based biotechnology firm Surrozen has selected TransPerfect Life Sciences’ Trial Interactive eClinical Platform for the comprehensive management of trial master files (TMF).
The company required a technology and service solution that can offer an extensible electronic trial master file (eTMF) paired with TMF services to streamline and own its operations.
Surrozen choose TransPerfect’s platform, along with its eTMF and TMF solutions, for creating a centralised and quality-focused approach for TMF management.
TransPerfect’s Trial Interactive technology simplifies and automates the clinical processes for CROs, sponsors, and sites worldwide.
Study teams can use the technology to streamline their operations by improving operational excellence, expediting timelines, cutting unnecessary expenses, and reducing compliance risks.
The eClinical platform offers an author-to-archive collaboration experience, with solutions for e-learning, site selection, site activation, quality, clinical document management, and compliance training.
The 21 CFR Part 11-compliant unified platform has been developed for clinical professionals with a practical approach to innovation and collaboration.
Surrozen Development Operations vice-president Michael Lauw said: “Trial Interactive provides an important combination of IT and service solutions for a growing company: a scalable eTMF packaged with implementation, validation, management, and oversight services.
“It was a bonus to learn about their partnership with LMK Consulting. Trial Interactive’s TMF expertise was essential to our decision.”
TransPerfect’s electronic trial solutions simplifies clinical operations. It improves quality, expedites timelines, enables collaboration, helps with passing inspections, and captures the complete story of study.
TransPerfect president and CEO Phil Shawe said: “Surrozen’s work in tissue regeneration is innovative and important, and we are proud that Trial Interactive has been chosen to support Surrozen’s TMF management processes.”